Stimulation of hepatic phenylalanine hydroxylase activity but not Pah-mXNA expression upon oral loading of tetrahydrobiopterin in normal mice

被引:21
作者
Scavelli, R
Ding, ZB
Blau, N
Haavik, J
Martínez, A
Thöny, B
机构
[1] Univ Zurich, Dept Pediat, Div Clin Chem, CH-8006 Zurich, Switzerland
[2] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway
关键词
PKU; tetrahydrobiopterin; phenylalanine hydroxylase; chemical-chaperone;
D O I
10.1016/j.ymgme.2005.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tetrahydrobiopterin (BH4) supplementation in patients with BH4-responsive phenylalanine hydroxylase (PAH) deficiency is an alternative to low-phenylalanine diet. To further investigate hepatic BH4-responsiveness, oral administration of 50 mg BH4/kg/day for 5 weeks was performed in wild-type mice. We observed a 2-fold increase in PAH protein by quantitative Western blot analysis and a 1.7-fold increase in enzyme activity, but no change in Pah-mRNA expression by quantitative real-time PCR analysis in treated mice compared to controls. Our findings support the proposed chemical-chaperone effect of BH4 to protect PAR (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:S153 / S155
页数:3
相关论文
共 18 条
[1]   High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002 [J].
Bernegger, C ;
Blau, N .
MOLECULAR GENETICS AND METABOLISM, 2002, 77 (04) :304-313
[2]   The metabolic and molecular bases of tetrahydroblopterin-responsive phenylalanine hydroxylase deficiency [J].
Blau, N ;
Erlandsen, H .
MOLECULAR GENETICS AND METABOLISM, 2004, 82 (02) :101-111
[3]  
BLAU N, 2001, METABOLIC MOL BASES, V8, P1725
[4]  
Bowersox J, 2001, PEDIATRICS, V108, P972
[5]   Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts-/- mice rescued by feeding neurotransmitter precursors and H4-biopterin [J].
Elzaouk, L ;
Leimbacher, W ;
Turri, M ;
Ledermann, B ;
Bürki, K ;
Blau, N ;
Thöny, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) :28303-28311
[6]   Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations [J].
Erlandsen, H ;
Pey, AL ;
Gámez, A ;
Pérez, B ;
Desviat, LR ;
Aguado, C ;
Koch, R ;
Surendran, S ;
Tyring, S ;
Matalon, R ;
Scriver, CR ;
Ugarte, M ;
Martínez, A ;
Stevens, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) :16903-16908
[7]   Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration [J].
Fiege, B ;
Ballhausen, D ;
Kierat, L ;
Leimbacher, W ;
Goriounov, D ;
Schircks, B ;
Thöny, B ;
Blau, N .
MOLECULAR GENETICS AND METABOLISM, 2004, 81 (01) :45-51
[8]   The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria [J].
Harding, CO ;
Neff, M ;
Wild, K ;
Jones, K ;
Elzaouk, L ;
Thöny, B ;
Milstien, S .
MOLECULAR GENETICS AND METABOLISM, 2004, 81 (01) :52-57
[9]   Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency [J].
Kure, S ;
Sato, K ;
Fujii, K ;
Aoki, Y ;
Suzuki, Y ;
Kato, S ;
Matsubara, Y .
MOLECULAR GENETICS AND METABOLISM, 2004, 83 (1-2) :150-156
[10]   Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency [J].
Kure, S ;
Hou, DC ;
Ohura, T ;
Iwamoto, H ;
Suzuki, S ;
Sugiyama, N ;
Sakamoto, O ;
Fujii, K ;
Matsubara, Y ;
Narisawa, K .
JOURNAL OF PEDIATRICS, 1999, 135 (03) :375-378